OneDigital Investment Advisors’s Jazz Pharmaceuticals JAZZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$571K Sell
3,022
-573
-16% -$100K 0.01% 886
2025
Q4
$611K Sell
3,595
-220
-6% -$33.7K 0.01% 869
2025
Q3
$503K Sell
3,815
-63
-2% -$7.56K 0.01% 930
2025
Q2
$412K Sell
3,878
-54
-1% -$5.87K ﹤0.01% 989
2025
Q1
$488K Buy
3,932
+377
+11% +$49.2K 0.01% 866
2024
Q4
$438K Buy
3,555
+926
+35% +$109K 0.01% 942
2024
Q3
$293K Sell
2,629
-184
-7% -$20.2K ﹤0.01% 1163
2024
Q2
$300K Buy
+2,813
New +$309K ﹤0.01% 1113
2018
Q3
Sell
-130
Closed -$22K 1107
2018
Q2
$22K Hold
130
﹤0.01% 777
2018
Q1
$20K Buy
+130
New +$19.1K ﹤0.01% 819

Other funds holding JAZZ

OneDigital Investment Advisors's JAZZ Position: Q1 2026 in Review

OneDigital Investment Advisors reduced its Jazz Pharmaceuticals (JAZZ) stake by 16% in Q1 2026, selling an estimated $100K and leaving 3,022 shares worth $571K. The position accounts for 0.01% of the portfolio, ranked #886.

OneDigital Investment Advisors first reported a position in JAZZ in Q1 2018 and has held it in 10 quarters since. The position peaked at $611K in Q4 2025. 571 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

  • OneDigital Investment Advisors held 3,022 shares of Jazz Pharmaceuticals worth $571K as of Q1 2026.
  • OneDigital Investment Advisors sold 573 Jazz Pharmaceuticals shares in Q1 2026, an estimated $100K.
  • Jazz Pharmaceuticals made up 0.01% of OneDigital Investment Advisors's portfolio in Q1 2026, its #886 holding.
  • OneDigital Investment Advisors first reported a position in Jazz Pharmaceuticals in Q1 2018 and has held it in 10 quarters since.
  • OneDigital Investment Advisors's Jazz Pharmaceuticals position peaked at $611K in Q4 2025.
  • 571 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on OneDigital Investment Advisors's 13F filing for Q1 2026, filed 8 May 2026.